These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 16236111)
21. A retrospective study of Octaplex in the treatment of bleeding in patients with haemophilia A complicated by inhibitors. Berntorp E; Figueiredo S; Futema L; Pock K; Knaub S; Walter O; Trawnicek L; Römisch J Blood Coagul Fibrinolysis; 2010 Sep; 21(6):577-83. PubMed ID: 20644466 [TBL] [Abstract][Full Text] [Related]
22. Combined treatment with APCC (FEIBA®) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A--a two-centre experience. Holmström M; Tran HT; Holme PA Haemophilia; 2012 Jul; 18(4):544-9. PubMed ID: 22348384 [TBL] [Abstract][Full Text] [Related]
23. Prophylaxis therapy in paediatric patients with haemophilia: a survey of clinical management trends in Italy. Castaman G; Rocino A; Mazzucconi MG; Zanon E; Gagliano F; Molinari AC Blood Transfus; 2015 Oct; 13(4):631-8. PubMed ID: 26057481 [TBL] [Abstract][Full Text] [Related]
24. Use of prothrombin complex concentrates for prophylaxis and treatment of bleeding episodes in patients with hereditary deficiency of prothrombin, factor VII, factor X, protein C protein S, or protein Z. Lechler E Thromb Res; 1999 Aug; 95(4 Suppl 1):S39-50. PubMed ID: 10499908 [No Abstract] [Full Text] [Related]
25. Home treatment of haemophilia patients with inhibitors. Oyesiku JO Haemophilia; 2011 Mar; 17(2):173-8. PubMed ID: 21070497 [TBL] [Abstract][Full Text] [Related]
26. Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors. Zanon E; Iorio A; Rocino A; Artoni A; Santoro R; Tagliaferri A; Coppola A; Castaman G; Mannucci PM; ; Barillari G; Dragani A; Gamba G; Giuffrida A; Lapecorella M; Mancuso G; Lucia L; Mazzucconi MG; Messina M; Musso R; De Martis F; Rossetti G; Schinco P; Spiezia L; Valdrè L Haemophilia; 2012 Jan; 18(1):39-45. PubMed ID: 21752159 [TBL] [Abstract][Full Text] [Related]
28. Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia. Baudo F; de Cataldo F; Gaidano G; Haematologica; 2004 Jun; 89(6):759-61. PubMed ID: 15194550 [TBL] [Abstract][Full Text] [Related]
29. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies. Holme PA; Brosstad F; Tjønnfjord GE Haemophilia; 2005 Sep; 11(5):510-5. PubMed ID: 16128896 [TBL] [Abstract][Full Text] [Related]
30. Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical management. Benson G; Auerswald G; Dolan G; Duffy A; Hermans C; Ljung R; Morfini M; Šalek SZ Blood Transfus; 2018 Nov; 16(6):535-544. PubMed ID: 29328905 [TBL] [Abstract][Full Text] [Related]
31. A consensus statement on clinical trials of bypassing agent prophylaxis in inhibitor patients. Teitel J; Berntorp E; Dolan G; Fischer K; Gringeri A; Kessler C; Lambert T; Leissinger C; Nemes L; Shima M Haemophilia; 2011 May; 17(3):516-21. PubMed ID: 21371181 [TBL] [Abstract][Full Text] [Related]
32. Kreuth IV: European consensus proposals for treatment of haemophilia with coagulation factor concentrates. Giangrande PLF; Peyvandi F; O'Mahony B; Behr-Gross ME; Hilger A; Schramm W; Mannucci PM Haemophilia; 2017 May; 23(3):370-375. PubMed ID: 28401658 [TBL] [Abstract][Full Text] [Related]
33. Recommendations for the treatment of factor VIII inhibitors: from the UK Haemophilia Centre Directors' Organisation Inhibitor Working Party. Hay CR; Colvin BT; Ludlam CA; Hill FG; Preston FE Blood Coagul Fibrinolysis; 1996 Mar; 7(2):134-8. PubMed ID: 8735802 [TBL] [Abstract][Full Text] [Related]
34. Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. Tengborn L; Baudo F; Huth-Kühne A; Knoebl P; Lévesque H; Marco P; Pellegrini F; Nemes L; Collins P; BJOG; 2012 Nov; 119(12):1529-37. PubMed ID: 22901076 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of FEIBA for acute bleeding and surgical haemostasis in haemophilia A patients with inhibitors: a multicentre registry in Turkey. Zülfikar B; Aydogan G; Salcioglu Z; Oner AF; Kavakli K; Gursel T; Zülfikar H; Haemophilia; 2012 May; 18(3):383-91. PubMed ID: 22103429 [TBL] [Abstract][Full Text] [Related]
36. Guidelines for the management of hemophilia. Srivastava A; Brewer AK; Mauser-Bunschoten EP; Key NS; Kitchen S; Llinas A; Ludlam CA; Mahlangu JN; Mulder K; Poon MC; Street A; Haemophilia; 2013 Jan; 19(1):e1-47. PubMed ID: 22776238 [TBL] [Abstract][Full Text] [Related]
37. Toward optimal therapy for inhibitors in hemophilia. Kempton CL; Meeks SL Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):364-71. PubMed ID: 25696880 [TBL] [Abstract][Full Text] [Related]